FDA Issues Alert About Blood Clams in Relation to Hepatitis A Outbreak

Key Takeaways

• FDA alerts consumers about La Serranita frozen blood clams from Ecuador
• Outbreak linked to 2025‑2026 hepatitis A cases across New York
• Frozen clams' long shelf life extends contamination risk nationwide
• Label check: “Concha Negra,” “Fresh Frozen,” 16‑oz net weight
• Hepatitis A spreads before symptoms, emphasizing vaccination importance

Pulse Analysis

The U.S. Food and Drug Administration’s latest public health alert centers on fresh‑frozen blood clams imported from Ecuador and marketed under the La Serranita brand. These clams, also known as concha negra, have been tied to a hepatitis A outbreak that began in July 2025 and produced its most recent case in February 2026. Because hepatitis A is highly contagious and can be transmitted before symptoms appear, the FDA’s warning aims to halt further exposure while state health officials continue epidemiological investigations.

The implicated clams traveled through a typical North‑American seafood distribution chain: harvested in Ecuador, frozen for transport, then shipped to a New Jersey importer before reaching a New York dealer. Their long shelf life—often months in a freezer—means contaminated product can linger in retail inventories and even reach secondary markets before detection. This complicates recall efforts, as frozen goods are less likely to be returned promptly, increasing the window for consumer exposure. The alert therefore stresses precise label verification to isolate affected batches quickly.

From a public‑health perspective, the episode reinforces two critical defenses against hepatitis A: vaccination and safe food handling. While a vaccine exists and is recommended for travelers and at‑risk populations, many adults remain unvaccinated, leaving them vulnerable to food‑borne transmission. Consumers should discard any La Serranita clams matching the alert’s description and practice thorough hand hygiene when handling raw seafood. Industry players are expected to tighten import screening and consider additional pathogen testing to restore confidence in frozen shellfish products.